TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/21/24 18:38 | 8/19/24 | QNCX | Quince Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Hannah Brendan | CA | O | CHIEF BU | P.m | 24 | 0.6209 | 0 | 39 | 15 | 297 | D | ||||||||||||||
6/5/24 14:37 | 6/4/24 | QNCX | Quince Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Hannah Brendan | CA | O | CHIEF BU | M.d | 31 | 0.5500 | 0 | 56 | 28 | 258 | D | ||||||||||||||
8/9/23 18:21 | 8/8/23 | QNCX | Quince Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Hannah Brendan | CA | O | Chief Bu | P | 88 | 1.22 | 0 | 72 | 55 | 202 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |